$12.03
-0.40-3.22%
al cierre: -
$12.19
0.161.33%
After hour: Sep 11, 4:22 PM EDT
FibroGen informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de FibroGen utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FGEN | FibroGen | -$4.25 | -$4.01 | — | — | $46.33M | $1.64M | — | — | 11/11/2025 | |
FGEN | FibroGen | -$4.00 | -$0.30 | -$1.88 | -526.67% | $50.64M | $2.88M | $1.35M | -53.28% | 08/11/2025 | |
FGEN | FibroGen | -$8.25 | $0.50 | $1.25 | 150.00% | $55.90M | $2.00M | $2.74M | 36.95% | 05/12/2025 | |
FGEN | FibroGen | -$14.25 | -$5.00 | -$2.00 | 60.00% | $3.63M | $24.90M | $3.14M | -87.41% | 03/17/2025 | |
FGEN | FibroGen | -$13.00 | -$7.50 | -$4.25 | 43.33% | $40.13M | $34.76M | $46.33M | 33.29% | 11/12/2024 | |
FGEN | FibroGen | -$22.50 | -$6.50 | -$4.00 | 38.46% | $44.32M | $34.66M | $50.64M | 46.11% | 08/06/2024 | |
FGEN | FibroGen | -$20.50 | -$10.50 | -$8.25 | 21.43% | $36.16M | $36.67M | $55.90M | 52.45% | 05/06/2024 | |
FGEN | FibroGen | -$17.50 | -$10.50 | -$14.25 | -35.71% | $34.37M | $38.90M | $27.14M | -30.24% | 02/26/2024 | |
FGEN | FibroGen | -$24.50 | -$17.00 | -$13.00 | 23.53% | $15.73M | $36.84M | $40.13M | 8.94% | 11/06/2023 | |
FGEN | FibroGen | -$19.50 | -$18.00 | -$22.50 | -25.00% | $29.81M | $34.17M | $44.32M | 29.70% | 08/07/2023 | |
FGEN | FibroGen | -$17.00 | -$18.75 | -$20.50 | -9.33% | $60.83M | $31.84M | $36.16M | 13.57% | 05/08/2023 | |
FGEN | FibroGen | -$36.25 | -$23.50 | -$17.50 | 25.53% | $16.54M | $24.04M | $34.37M | 42.96% | 02/27/2023 | |
FGEN | FibroGen | $13.50 | -$20.25 | -$24.50 | -20.99% | $155.97M | $31.59M | $15.73M | -50.19% | 11/07/2022 | |
FGEN | FibroGen | -$36.25 | -$23.50 | -$19.50 | 17.02% | $24.36M | $34.39M | $29.81M | -13.33% | 08/08/2022 | |
FGEN | FibroGen | -$19.55 | -$20.75 | -$17.00 | 18.07% | $38.43M | — | $60.83M | — | 05/09/2022 | |
FGEN | FibroGen | -$16.00 | -$17.00 | -$36.25 | -113.24% | $65.00M | $44.23M | $16.54M | -62.60% | 02/28/2022 | |
FGEN | FibroGen | $8.75 | — | $13.50 | — | $44.03M | $143.46M | $155.97M | 8.72% | 11/09/2021 | |
FGEN | FibroGen | -$23.75 | -$11.25 | -$36.25 | -222.22% | $42.89M | $71.38M | $24.36M | -65.87% | 08/09/2021 | |
FGEN | FibroGen | -$22.25 | -$21.75 | -$19.55 | 10.11% | $24.40M | $41.79M | $38.43M | -8.04% | 05/10/2021 | |
FGEN | FibroGen | -$28.00 | — | -$16.00 | — | $7.97M | — | $65.00M | — | 03/01/2021 | |
FGEN | FibroGen | -$14.25 | — | $8.75 | — | $33.17M | — | $44.03M | — | 11/05/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-11 | $-1.88 | $-0.30 | -526.7 % |
Q1 | 2025-05-12 | $1.25 | $0.50 | 150.0 % |
Q4 | 2025-03-17 | $-2.00 | $-5.00 | 60.0 % |
Q3 | 2024-11-12 | $-4.25 | $-7.50 | 43.3 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-11 | $1.35M | $2.89M | -53.3 % |
Q1 | 2025-05-12 | $2.74M | $2.00M | 37.0 % |
Q4 | 2025-03-17 | $3.14M | $24.90M | -87.4 % |
Q3 | 2024-11-12 | $46.33M | $34.76M | 33.3 % |
Está previsto que FibroGen (FGEN) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 11, 2025 para el Q2.
El BPA real fue de $-1.88, que no alcanzó la estimación de $-0.30.
Los ingresos reales fueron $1.3M, que no alcanzó la estimación de $2.9M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.